1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. South America ECMO Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. South America ECMO Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. South America ECMO Market Regional Analysis
6.1 South America ECMO Market Overview
6.2 South America ECMO Market Revenue 2020-2028 (US$ Million)
6.3 South America ECMO Market Forecast Analysis
7. South America ECMO Market Analysis – by Modality
7.1 Venoarterial ECMO
- 7.1.1 Overview
- 7.1.2 Venoarterial ECMO: South America ECMO Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Venovenous ECMO
- 7.2.1 Overview
- 7.2.2 Venovenous ECMO: South America ECMO Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Arteriovenous ECMO
- 7.3.1 Overview
- 7.3.2 Arteriovenous ECMO: South America ECMO Market – Revenue and Forecast to 2031 (US$ Million)
8. South America ECMO Market Analysis – by Application
8.1 Respiratory
- 8.1.1 Overview
- 8.1.2 Respiratory: South America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Cardiology
- 8.2.1 Overview
- 8.2.2 Cardiology: South America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
9. South America ECMO Market Analysis – by Age Group
9.1 Adults
- 9.1.1 Overview
- 9.1.2 Cardiology: South America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Pediatrics
- 9.2.1 Overview
- 9.2.2 Cardiology: South America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Neonates
- 9.3.1 Overview
- 9.3.2 Cardiology: South America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
10. South America ECMO Market – South and Central America Analysis
10.1 South and Central America
- 10.1.1 South America ECMO Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.1.1.1 South America ECMO Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 Brazil:
South America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 Brazil: South America ECMO Market Breakdown, by Modality
- 10.1.1.1.2 Brazil: South America ECMO Market Breakdown, by Application
- 10.1.1.1.3 Brazil: South America ECMO Market Breakdown, by Age Group
- 10.1.1.2 Argentina:
South America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Argentina: South America ECMO Market Breakdown, by Modality
- 10.1.1.2.2 Argentina: South America ECMO Market Breakdown, by Application
- 10.1.1.2.3 Argentina: South America ECMO Market Breakdown, by Age Group
- 10.1.1.3 Rest of South and Central America :
South America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Rest of South and Central America : South America ECMO Market Breakdown, by Modality
- 10.1.1.3.2 Rest of South and Central America : South America ECMO Market Breakdown, by Application
- 10.1.1.3.3 Rest of South and Central America : South America ECMO Market Breakdown, by Age Group
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. South America ECMO Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 ABIOMED Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Braile Biomedica
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Fresenius Medical Care AG & Co KGaA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Getinge AB
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 LivaNova Plc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Medtronic Plc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 MicroPort Scientific Corporation
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Nipro Medical Corporation
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Terumo Group
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For South America ECMO Market
